Solid Biosciences (SLDB) Cash & Equivalents Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 4.69% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -16.07% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.88% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 21.66% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 36.53% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 21.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.74% |
| Dec 31, 2025 | -27.22% |
| Sep 30, 2025 | 7.94% |
| Jun 30, 2025 | 36.76% |
| Mar 31, 2025 | 17.54% |
| Dec 31, 2024 | -12.35% |
| Sep 30, 2024 | -16.26% |
| Jun 30, 2024 | -21.82% |
| Mar 31, 2024 | -24.06% |
| Dec 31, 2023 | -21.85% |
| Sep 30, 2023 | 25.52% |
| Jun 30, 2023 | 30.96% |
| Mar 31, 2023 | 45.44% |
| Dec 31, 2022 | 26.90% |
| Sep 30, 2022 | -19.93% |
| Jun 30, 2022 | 1.35% |
| Mar 31, 2022 | 33.66% |
| Dec 31, 2021 | 11.32% |
| Sep 30, 2021 | -5.36% |
| Jun 30, 2021 | 11.16% |
| Mar 31, 2021 | 17.60% |
| Dec 31, 2020 | 43.80% |
| Sep 30, 2020 | 18.20% |
| Jun 30, 2020 | 7.61% |
| Mar 31, 2020 | 22.28% |